Thus, use of platinum salts may be a more rational treatment approach in breast cancers with either genetic or epigenetic inactivation BRCA1. Indeed, platinum compounds are more effective than anthracyclines in treating tumors arising in a Brca1/p53 mouse model of spontaneous breast cancer [41,51]. The gene discussed is TP53; the disease is breast cancer.